Cover Image

Cancer Treatment Drugs Markets in China (12 Full Research Reports Collection)

“Single report purchase is available, $4000 for a single user license, $8000 for a corporate license”

Abstract

China's demand for cancer treatment drugs markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This is a collection of 12 full market research reports on lung cancer, breast cancer, prostate cancer, leukemia, ovrian cancer, colon cancer, cevical cancer, brain cancer, bladder cancer, liver cancer, kidney cancer, and skin cancer treatment drugs. These new studies examine China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.

Table of Contents

Chinese Markets for Lung Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II.BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population
  • Foreign Investment
  • Foreign Trade
    • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. LUNG CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Lung Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Lung Cancer Treatment Drugs Industry Capacity
  • Major Producer Facility Locations and Output
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. LUNG CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Lung Cancer Treatment Drugs by Region
  • Lung Cancer Drugs Production and Demand
  • Cytotoxic Drugs
  • Anti-drug metabolism
  • Antibiotic
  • Alkaloids Drugs
  • Hormones Drugs
  • Other Lung Cancer Treatment Drugs
  • Lung Cancer Treatment Drugs Imports and Exports
  • Lung Cancer Drugs Imports
  • Lung Cancer Drugs Exports
  • Pricing Trend

V. LUNG CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Lung Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Plastic Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. LUNG CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Major Plastics Producer Profiles
  • Distributors and Trading Companies
  • Associations and Research Institutes
  • Major End-Users

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. LUNG CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Lung Cancer Treatment Drugs Industry Output
  • Major Producer Facility Location
  • Major Lung Cancer Treatment Drugs Producer Output
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. LUNG CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Lung Cancer Treatment Drugs Production and Demand
  • Demand of Lung Cancer Treatment Drugs by Region
  • Cytotoxic Drugs Production and Demand
  • Anti-drug Metabolism Production and Demand
  • 2004~2006 Market Share of Antibiotic
  • Antibiotics Drugs Production and Demand
  • Alkaloids Drugs Production and Demand
  • Total hormone Drugs Production and Demand
  • Other Lung Cancer Treatment Drugs Production
  • China Lung Cancer Treatment Drugs Imports and Exports

V. LUNG CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Total Lung Cancer Drugs Consumption by Market
  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. LUNG CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Lung Cancer Treatment Drugs Output in China
  • All kinds of lung cancer drug Market Share
  • Lung Cancer Treatment Drugs Capacity, Output and Demand

IV. LUNG CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Total Lung Cancer Treatment Drugs Production and Demand
  • 1999 to 2001 in 6 cities in the hospital of Lung Cancer drug use changes
  • Total Lung Cancer Treatment Drugs Imports and Exports

V. LUNG CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Lung Cancer Drugs Demand by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Breast Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
    • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Industry Structure
  • Market Size
  • Market Growth Driver
  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Overview
  • Breast Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Pricing Trend

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Breast Cancer Treatment Drug Markets Outlook Overview Concrete Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
    • China's Distribution System
    • Breast Cancer Treatment Drug Distribution Channels
    • Transportation and Freight Infrastructure
    • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY

  • Breast Cancer Treatment Drug Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Breast Cancer Treatment Drug Producer Sales Volume and Market Share
  • Major Foreign Investments

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Total Breast Cancer Treatment Drugs Sales Volume
  • Breast Cancer Treatment Drug Major Producer and Their Market Share
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Paclitaxel Major Producer and Their Market Share
  • Fluoropyrimidines Major Producer and Their Market Share
  • Anthracycline Antibiotics Major Producer and Their Market Share
  • Targeted Therapy Drug Major Producer and Their Market Share
  • Therapertic Antibody Major Producer and Their Market Share
  • Small Molecules Drug Major Producer and Their Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
  • Endocrine Therapy Drug Major Producer and Their Market Share
  • Anti-estrogens Major Producer and Their Market Share
  • Progesterone Major Producer and Their Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
  • LH-RH Major Producer and Their Market Share
  • Breast Cancer Treatment Drugs Import

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Breast Cancer Treatment Drug Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Endocrine Therapy Drug Sales Volume by Drugs Classification
  • Breast Cancer Treatment Drug Sales Volume

IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND

  • Breast Cancer Treatment Drug Sales Volume
  • Chemotherapeutic Drug Sales Volume and Market Share
  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Paclitaxel Sales Volume and Market Share
  • Fluoropyrimidines Sales Volume and Market Share
  • Anthracycline Antibiotics Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Therapertic Antibody Sales Volume and Market Share
  • Small Molecules Drug Sales Volume and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share
  • Endocrine Therapy Sales Volume by Drugs Classification
  • Anti-estrogens Sales Volume and Market Share
  • Progesterone Sales Volume and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
  • LH-RH Sales Volume and Market Share
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug Import and Market Share
  • Chemotherapeutic Drug Import by Drugs Classification
  • Paclitaxel Import and Market Share
  • Fluoropyrimidines Import and Market Share
  • Anthracycline Antibiotics Import and Market Share
  • Targeted Therapy Drug Import and Market Share
  • Targeted Therapy Drug Import by Drugs Classification
  • Therapertic Antibody Import and Market Share
  • Small Molecules Drug Import and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
  • Endocrine Therapy Drug Import and Market Share
  • Endocrine Therapy Drug Import by Drugs Classification
  • Anti-estrogens Import and Market Share
  • Progesterone Import and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
  • LH-RH Import and Market Share

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

I. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Prostate Cancer Treatment Drugs

I.INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II.BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Prostate Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Prostate Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Prostate Cancer Treatment Drugs by Region in 2008
  • Prostate Cancer Treatment Drugs Sales Volume
  • Bicalutamide Sales volume and market share
  • Flutamide Sales volume and market share
  • Cyproterone Acetate Sales volume and market share
  • Megestrol Acetate Sales volume and market share
  • Triptorelin Acetate Sales volume and market share
  • Goserelin Acetate Sales volume and market share
  • Leuprorelin Acetate Sales volume and market share
  • Estramustine disodium phosphate Sales volume and market share
  • Docetaxel Sales volume and market share
  • Other Prostate Cancer Treatment Drugs Sales volume and market share
  • Prostate Cancer Treatment Drugs Imports
  • Pricing Trends

V. PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Prostate Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • Distribution System in China
  • China's Distribution System
  • Prostate Cancer Treatment Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • Market Entry Channels
  • Exporting to China
  • Export Market Overview
  • Chinese Trading Practice
  • Chemical Trade Companies
  • Import Restrictions in China
  • Technology Licensing
  • Technology Licensing Overview
  • Intellectual Property Protection
  • Joint Venture
  • Joint Venture Overview
  • Advantages and Disadvantages
  • Wholly Owned Enterprises
  • Foreign Wholly Owned Enterprises Overview
  • Advantages and Disadvantages
  • Other Market Entry Channels
  • Setting up Sales Offices
  • Selling to China through Attending Trade Fairs
  • Contacting Chinese Companies
  • Advertising
  • Market Entry Strategies
  • Understanding Differences
  • Business Practice Differences
  • Knowledge of Regulations and Restrictions
  • Dealing with Governments

VII. PROSTATE CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Prostate Cancer Treatment Drugs Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Prostate Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Prostate Cancer Treatment Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investments

IV.PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Total Prostate Cancer Treatment Drugs Sales Volume
  • Prostate Cancer Treatment Drug Major Producer and Their Market Share
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Bicalutamide Major Producer and Their Market Share
  • Flutamide Major Producer and Their Market Share
  • Cyproterone Acetate Major Producer and Their Market Share
  • Megestrol Acetate Major Producer and Their Market Share
  • Luteinizing Hormone Releasing Hormonr Analogue Major Producer and Their Market Share
  • Triptorelin Major Producer and Their Market Share
  • Goserelin Acetate Major Producer and Their Market Share
  • Leuprorelin Acetate Major Producer and Their Market Share
  • Estramustine phosphate Major Producer and Their Market Share
  • Docetaxel Major Producer and Their Market Share
  • Prostate Cancer Treatment Drugs Import

V.PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. NTRODUCTION

  • Prostate Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Prostate Cancer Treatment Drugs Sales Volume
  • Androgen Receptor Antagonist Sales Volume by Drugs Classification
  • Luteinizing Hormone Releasing Hormonr Analogue Sales Volume by Drugs Classification
  • Prostate Cancer Treatment Drugs Sales Volume

IV. PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Prostate Cancer Treatment Drugs Sales Volume
  • Worldwide Prostate Cancer Treatment Drugs Demand by region
  • Androgen Receptor Antagonist Sales Volume and Market Share
  • Androgen Receptor Antagonist Sales Volume by Drugs Classification
  • Bicalutamide Sales Volume and Market Share
  • Flutamide Sales Volume and Market Share
  • Cyproterone Acetate Sales Volume and Market Share
  • Megestrol Acetate Sales Volume and Market Share
  • Luteinizing Hormone Releasing Hormonr Analogue Sales Volume and Market Share
  • Luteinizing Hormone Releasing Hormonr Analogue Sales Volume by Drugs Classification
  • Triptorelin Sales Volume and Market Share
  • Goserelin Acetate Sales Volume and Market Share
  • Leuprorelin Acetate Sales Volume and Market Share
  • Estramustine phosphate Sales Volume and Market Share
  • Docetaxel Sales Volume and Market Share
  • Other Prostate Cancer Treatment Drugs Sales Volume and Market Share
  • Prostate Cancer Treatment Drugs Import Volume
  • Androgen Receptor Antagonist Import and Market Share
  • Androgen Receptor Antagonist Import by Drugs Classification
  • Bicalutamide Import Volume and Market Share
  • Flutamide Import Volume and Market Share
  • Cyproterone Acetate Import Volume and Market Share
  • Megestrol Acetate Import Volume and Market Share
  • Luteinizing Hormone Releasing Hormone Analogue Import Volume and Market Share
  • Luteinizing Hormone Releasing Hormone Analogue Import by Drugs Classification
  • Leuprorelin Acetate Import Volume and Market Share
  • Triptorelin Import Volume and Market Share
  • Goserelin Acetate Import Volume and Market Share
  • Estramustine phosphate Import Volume and Market Share
  • Docetaxel Import Volume and Market Share
  • Other Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Leukemia Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
    • Key Economic Indicators
    • Industrial Output
    • Population and Labor
    • Foreign Investment
    • Foreign Trade
  • Financial and Tax Regulations
    • Banking System and Regulations
    • Foreign Exchange
    • Taxes, Tariff and Custom Duties

III. LEUKEMIA TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Leukemia Treatment Drugs Industry Structure
    • Market Size
    • Market Growth Drivers
  • . Leukemia Treatment Drugs Industry Capacity
  • Major Producer Facility Location and Output
    • Major Immune Stimulators Agents Disease Drugs Producer Facility Locations, Output and Market Share
  • Major Plant Alkaloids and Natural Medicine Drugs Producer Facility Locations, Output and Market Share
  • Major Anti-metabolism Drugs Producer Facility Locations, Output and Market Share
  • Major Cytotoxic Antibiotics Drugs Producer Facility Locations, Output and Market Share
  • Major Hormones Drugs Producer Facility Locations, Output and Market Share
  • Major Alkylating Agent Producer Facility Locations, Output and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. LEUKEMIA TREATMENT DRUGS OUTPUT AND DEMAND

  • Overview
    • Leukemia Treatment Drugs Classification, Demand, Output and Share
  • . Leukemia Treatment Drugs Output and Demand
  • . Immune Stimulators
  • . . Plant Alkaloids and Natural Medicine Drugs
  • . Anti-metabolism Drugs
  • Cytotoxic Antibiotics
  • Hormones Drugs
  • Alkylating agent
  • Leukemia Treatment Drugs Imports and Exports
  • Leukemia Treatment Drugs Imports
  • Leukemia Treatment Drugs Exports

V. LEUKEMIA TREATMENT DRUGS MARKET OUTLOOK

  • Leukemia Treatment Drugs Market Outlook Overview
  • Immune Stimulators Agents Outlook
    • Plant Alkaloids and Natural Medicine Drugs Industry Outlook
    • Anti-metabolism Drugs Outlook
  • Cytotoxic Antibiotics Outlook
  • Hormones Drugs Outlook
  • Alkylating Agents Outlook

VI. MARKETING STRATEGIES

  • China Market Entry Overview
    • China's Distribution System
    • Special Rubber Distribution Channels
    • Transportation and Freight Infrastructure
    • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. LEUKEMIA TREATMENT DRUGS PRODUCERS DIRECTORY

  • Leukemia Treatment Drugs Producer Profiles

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary
  • Leukemia Treatment Drugs Supply and Demand Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
  • Key Commodity Exports from China
  • China's Exports to its Leading Trade Partners
  • Key Commodity Imports into China
  • China's Imports from Its Leading Trade Partners

III. LEUKEMIA TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Leukemia Treatment Drugs Industry Capacity in Classification
  • Leukemia Treatment Drugs Industry Output in Classification
  • The Top Ten Producer Facility and Output
  • Major Producer Facility Location
  • Major Immune Simulators Agents Producer Facility Locations, Output and Market Share
  • Major Plant Alkaloids and Natural Medicine Disease Drugs Producer Facility Locations, Output and Market Share
  • Major Anti-metabolism Drugs Producer Facility Locations, Output and Market Share
  • Major Cytotoxic Antibiotics Drugs Producer Facility Locations, Output and Market Share
  • Major Anti-metabolism Disease Drugs Producer Facility Locations, Output and Market Share
  • Major Alkylating Agent Producer Facility Locations, Output and Market
  • Major Foreign Investment in China

IV. . LEUKEMIA TREATMENT DRUGS OUTPUT AND DEMAND

  • Leukemia Treatment Drugs Output and Demand
  • Leukemia Treatment Drugs Classification, Output and Percent
    • Immune Stimulators Agents Capacity, Output, Import, Export and Demand
  • Plant Alkaloids and Natural Medicine Drugs Capacity, Output, Import, Export and Demand
  • Anti-metabolism Drugs Capacity, Output, Import, Export and Demand
  • Cytotoxic antibiotics Capacity, Output, Import, Export and Demand
  • Hormones drugs Capacity, Output, Import, Export and Demand
  • Alkylating Agent Capacity, Output, Import, Export and Demand
  • China Leukemia Treatment Drugs Imports and Exports

V. LEUKEMIA TREATMENT DRUGS MARKET OUTLOOK

  • Leukemia Treatment Drugs Classification and Output Share by Market
    • Total Leukemia Treatment Drugs Demand by Market
    • Leukemia Treatment Drugs Classification and Demand Share by Market
  • Immune Stimulators Agents Classification Output and Share
  • Immune Stimulators Agents Output, Demand and Growth Rate
  • Major Immune Stimulators Agents Producer Facility Output and Locations
    • Plant Alkaloids and Natural Medicine Drugs Classification by Output and Share in 2008
  • Plant Alkaloids and Natural Medicine Drugs Output, Demand and Growth Rate
  • Many Plant Alkaloids and Natural Medicine Drugs Producer Facility Output and Locations
  • Plant Alkaloids and Natural medicine drugs Producer Facility Output and Locations
  • Anti-metabolism Drugs Classification Output and Share
  • Anti-metabolism Drugs Output, Demand and Growth Rate
  • Major Anti-metabolism Drugs Producer Facility Output and Locations
  • Cytotoxic Antibiotics Drugs Output and Share
  • Cytotoxic Antibiotics Drugs Output, Demand and Growth Rate
    • Major Cytotoxic Antibiotics Drugs Producer Output and Locations
  • Hormones Drugs Classification Output and Share
  • Hormones Drugs Output, Demand and Growth Rate
  • Major Hormones drugs Producer Output and Locations
  • Alkylating Agents Classification Output and Share
  • Alkylating Agents Output, Demand and Growth Rate
  • Major Alkylating Agents Producer Output and Locations

LIST OF CHARTS

I. INTRODUCTION

  • Leukemia Treatment Drugs Capacity, Output, Demand

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. LEUKEMIA TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Leukemia Treatment Drugs Capacity, Output and Demand
  • Leukemia Treatment Drugs Output in China
  • Leukemia Treatment Drugs Capacity in China

IV. LEUKEMIA TREATMENT DRUGS OUTPUT AND DEMAND

  • Total Leukemia Treatment Drugs Output and Demand
  • Leukemia Treatment Drugs Classification and Output Share
  • Immune Stimulators Agents Output
  • Immune Stimulators Agents Demand
    • Plant Alkaloids and Natural Medicine Drugs Output
  • Plant Alkaloids and Natural Medicine Drugs Demand
  • Antimetabolism Drugs Output
  • Antimetabolism Drugs Demand
    • Cytotoxic Antibiotics Output
  • Cytotoxic Antibiotics Demand
  • Hormones drugs Output
  • Hormones drugs Demand
  • Alkylating agent Output
  • Alkylating agent Demand
    • Total Leukemia Treatment Drugs Imports
    • Total Leukemia Treatment Drugs Exports

V. LEUKEMIA TREATMENT DRUGS MARKET OUTLOOK

  • Leukemia Treatment Drugs Classification and Output Share by Market
  • Leukemia Treatment Drugs Classification and Demand Share by Market
    • Immune Stimulators Agents Output and Growth Rate
    • Immune Stimulators Agents Demand and Growth Rate
    • Plant Alkaloids and Natural Medicine Drugs Output and Growth Rate
    • Plant Alkaloids and Natural Medicine Drugs Demand and Growth Rate
    • Anti-metabolism Drugs Output and Growth Rate
  • Anti-metabolism Drugs Demand and Growth Rate
    • Cytotoxic Antibiotics Drugs Output and Growth Rate
  • . Cytotoxic Antibiotics Drugs Demand and Growth Rate
  • Hormones Drugs Output and Growth Rate
  • Hormones Drugs Demand and Growth Rate
  • Alkylating Agent Output and Growth Rate
  • Alkylating Agent Demand and Growth Rate

IV. Marketing Strategies

  • China's Distribution Channel

Chinese Markets for Ovarian Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
    • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Ovarian Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Ovarian Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
    • Paclitaxel
    • Platinum Anticancer Drugs
    • Fluoropyrimidines
    • Anthracycline Antibiotics
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Anti-estrogens
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
  • Ovarian Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Platinum Anticancer Drugs
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Ovarian Cancer Treatment Drugs Import
  • Chemotherapeutic Drug
  • Anthracycline Antibiotics
  • Fluoropyrimidines
  • Paclitaxel
  • Platinum Anticancer Drugs
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Pricing Trend

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Ovarian Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
    • China's Distribution System
    • Ovarian Cancer Treatment Drugs Distribution Channels
    • Transportation and Freight Infrastructure
    • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

I. OVARIAN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Ovarian Cancer Treatment Drugs Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
  • Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Ovarian Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share
  • Major Foreign Investments in China

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Ovarian Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Paclitaxel Major Producer and Their Market Share
  • Fluoropyrimidines Major Producer and Their Market Share
  • Anthracycline Antibiotics Major Producer and Their Market Share
  • Platinum Anticancer Drugs Major Producer and Their Market Share
  • Targeted Therapy Drug Major Producer and Their Market Share
  • Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Therapertic Antibody Major Producer and Their Market Share
  • Small Molecules Drug Major Producer and Their Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share in 2008
  • Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Endocrine Therapy Drug Major Producer and Their Market Share
  • Anti-estrogens Major Producer and Their Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
  • LH-RH Major Producer and Their Market Share
  • Ovarian Cancer Treatment Drugs Import

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Ovarian Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Market Share by Drugs Classification
    • Targeted Therapy Drug Market Share by Drugs Classification
    • Endocrine Therapy Drug Market Share by Drugs Classification
    • Ovarian Cancer Treatment Drugs Sales Volume

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Ovarian Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug Sales Volume and Market Share
  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Paclitaxel Sales Volume and Market Share
  • Fluoropyrimidines Sales Volume and Market Share
  • Anthracycline Antibiotics Sales Volume and Market Share
  • Platinum Anticancer Drugs Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Therapertic Antibody Sales Volume and Market Share
  • Small Molecules Drug Sales Volume and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume by Drugs Classification
  • Anti-estrogens Sales Volume and Market Share
  • Progesterone Sales Volume and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
  • LH-RH Sales Volume and Market Share
  • Ovarian Cancer Treatment Drugs Import
  • Chemotherapeutic Drug Import and Market Share
  • Chemotherapeutic Drug Import by Drugs Classification
  • Paclitaxel Import and Market Share
  • Anthracycline Antibiotics Import and Market Share
  • Fluoropyrimidines Import and Market Share
  • Placlitaxel Anticancer Drugs Import and Market Share
  • Platinum Anticancer Drugs Import and Market Share
  • Targeted Therapy Drug Import and Market Share
  • Targeted Therapy Drug Import by Drugs Classification
  • Therapertic Antibody Import and Market Share
  • Small Molecules Drug Import and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
  • Endocrine Therapy Drug Import and Market Share
  • Endocrine Therapy Drug Import by Drugs Classification
  • Anti-estrogens Import and Market Share
  • Progesterone Import and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
  • LH-RH Import and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Colon Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. COLON CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Colon Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Colon Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. COLON CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Colon Cancer Treatment Drugs by Region
  • Colon Cancer Treatment Drugs Sales Volume
  • Fluorouracil
  • Leucovorin
  • Oxaliplatin
  • Irinotecan
  • Capecitabine
  • Bevacizumab
  • Cetuximab
  • Other Colon Cancer Treatment Drugs
  • Colon Cancer Treatment Drugs Imports
  • Pricing Trend

V. COLON CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Colon Cancer Treatment Drugs Market Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Colon Cancer Treatment Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. COLON CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Colon Cancer Treatment Drugs Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. COLON CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Colon Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Colon Cancer Treatment Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investments in China

IV. COLON CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Total Colon Cancer Treatment Drugs Sales Volume
  • Fluorouracil Major Producer and Their Market Share
  • Leucovorin Major Producer and Their Market Share
  • Oxaliplatin Major Producer and Their Market Share
  • Irinotecan Major Producer and Their Market Share
  • Bevacizumab Major Producer and Their Market Share
  • Cetuximab Major Producer and Their Market Share
  • Colon Cancer Treatment Drugs Major Producer and Their Market Share
  • Colon Cancer Treatment Drugs Import

V. COLON CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

II. INTRODUCTION

  • Colon Cancer Treatment Drugs Sales Volume

III. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. COLON CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Colon Cancer Treatment Drugs Sales Volume

IV. COLON CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Total Colon Cancer Treatment Drugs Sales Volume
  • Worldwide Colon Cancer Treatment Drugs Demand by region
  • Fluorouracil Sales Volume and Market Share
  • Leucovorin Sales Volume and Market Share
  • Oxaliplatin Sales Volume and Market Share
  • Irinotecan Sales Volume and Market Share
  • Bevacizumab Sales Volume and Market Share
  • Cetuximab Sales Volume and Market Share
  • Other Colon Cancer Treatment Drugs Sales Volume and Market Share
  • Colon Cancer Treatment Drugs Import Volume
  • Fluorouracil Import Volume and Market Share
  • Leucovorin Import Volume and Market Share
  • Oxaliplatin Import Volume and Market Share
  • Irinotecan Import Volume and Market Share
  • Capecitabine Import Volume and Market Share
  • Bevacizumab Import Volume and Market Share
  • Cetuximab Import Volume and Market Share
  • Other Colon Cancer Treatment Drugs Import Volume and Market Share

VII. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Cervical Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
    • Key Economic Indicators
    • Industrial Output
    • Population and Labor
    • Foreign Investment
    • Foreign Trade
  • . Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Cervical Cancer Treatment Drugs Industry Structure
    • Market Size
    • Market Growth Drivers
  • . Cervical Cancer Treatment Drugs Industry Capacity
  • . Major Producer Facility Locations and Output
    • Market Share of Key Producers
  • Labor Cost
    • Potential Entrants
    • Major Distributors
  • . Major Foreign Investments
  • . Technology Development

IV. CERVICAL CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Pharmaceuticals by Region
    • Cervical Cancer Treatment Drugs Production and Demand
  • . Alkylating Agent
  • . Antimetabolisms
  • . Antibiotic
  • . Alkaloids Drugs
  • . Other Cervical Cancer Treatment Drugs
    • Cervical Cancer Treatment Drugs Imports and Exports
  • . Cervical Cancer Treatment Drugs Imports
  • . Cervical Cancer Treatment Drugs Exports
    • Pricing Trend

IV. CERVICAL CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Cervical Cancer Treatment Drugs Markets Outlook Overview
    • Government Regulation
    • Health Care Insurance Industry Overview
    • Consumer Spending Trends
    • Demographic Trends
    • Health Care Industry Trends
    • Hospitals and Hospital Beds
    • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
    • China's Distribution System
    • Cervical Cancer Treatment Drugs Distribution Channels
    • Transportation and Freight Infrastructure
    • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. CERVICAL CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Profiles of Cervical Cancer Treatment Drugs Producers and Major Suppliers

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Cervical Cancer Treatment Drugs Industry Output
    • Major Producer Facility Location
    • Major Cervical Cancer Treatment Drugs Producer Output
    • All kinds of Cervical Cancer Treatment Drugs Market Share
    • Market Share of Key Producers
    • Major Foreign Investment in China

IV. CERVICAL CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Cervical Cancer Treatment Drugs Production and Demand
  • Demand of Cervical Cancer Treatment Drugs by Region
    • Major Alkylating Agents Producer Output and Capacity
    • Alkylating Agents Production and Demand
    • Major Alkaloid Drugs Producer Output and Capacity
    • Alkaloid Drugs Production and Demand
  • Major Antibiotic Producer Output and Capacity
    • Antibiotic Production and Demand
  • Major Antimetabolisms Producer Output and Capacity
  • Antimetabolisms Production and Demand
  • Other Cervical Cancer Treatment Drugs Production and Demand
    • China Cervical Cancer Treatment Drugs Imports and Exports

V. CERVICAL CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Total Cervical Cancer Treatment Drugs Consumption by Market
    • All kinds of Cervical Cancer Treatment Drugs Market Share
  • China's Cervical Cancer Treatment Drugs Demand and Growth Rate
    • Consumer Spending Trends
    • Demographic Trends
    • Health Care Industry Trends
    • Hospitals and Hospital Beds
    • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • China's Cervical Cancer Treatment Capacity, Output, Demand

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Cervical Cancer Treatment Drugs Capacity in China
  • All kinds of Cervical Cancer Treatment Drugs Market Share
    • Cervical Cancer Treatment Drugs Capacity, Output and Demand

IV. CERVICAL CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Total Cervical Cancer Treatment Drugs Output and Demand
    • Total Cervical Cancer Treatment Drugs Import, Export and Net Import

V. CERVICAL CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Cervical Cancer Treatment Drugs Demand by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Brain Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

IV. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
    • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BRAIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Brain Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Driver
  • Brain Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. BRAIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overviews
  • Sales Volume of Brain Cancer Treatment Drugs by Region
  • Brain Cancer Treatment Drugs Sales Volume
  • Cytotoxic Drugs Sales Volume
    • Alkylating Agents
  • Antimetabolites
  • Anti-Tumor Antibiotics
  • Hormones
  • Mitotic Inhibitors
  • Steroids
  • Cytostatic Drugs Sales Volume
  • Drugs Aimed at Reducing Drug Resistance
  • Anti-Angiogenesis Inhibitors
  • Growth Factor Inhibitors
    • Brain Cancer Treatment Drugs Imports and Exports
  • Pricing Trends

V. CHINA BRAIN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Brain Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
    • China's Distribution System
    • Brain Cancer Treatment Drugs Distribution Channels
    • Transportation and Freight Infrastructure
    • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

I. BRAIN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Brain Cancer Treatment Drugs Producer Profiles and Directory
  • Major End-Users

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

V. BRAIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Brain Cancer Treatment Drugs Sales Volume and Market Share by Drugs Classification in 2008
  • Brain Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Brain Cancer Treatment Drugs Producer Sales Volume
  • Major Foreign Investment in China

VI. BRAIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Brain Cancer Treatment Drugs Sales Volume
  • Demand of Brain Cancer Treatment Drugs by Region
  • Alkylating Agents Sales Volume
  • Alkylating Agents Major Producer and Their Market Share
  • Antimetabolites Sales Volume
  • Antimetabolites Major Producer and Their Market Share
  • Anti-Tumor Antibiotics Sales Volume
  • Anti-Tumor Antibiotics Major Producer and Their Market Share
  • Hormones Sales Volume
  • Hormones Major Producer and Their Market Share
  • Mitotic Inhibitors Sales Volume
  • Mitotic Inhibitors Major Producer and Their Market Share
  • Steroids Sales Volume
  • Steroids Major Producer and Their Market Share
  • Drugs Aimed at Reducing Drug Resistance Sales Volume
  • Drugs Aimed at Reducing Drug Resistance Major Producer and Their Market Share
  • Anti-Angiogenesis Inhibitors Sales Volume
  • Anti-Angiogenesis Inhibitors Major Producer and Their Market Share
  • Growth Factor Inhibitors Sales Volume
  • Growth Factor Inhibitors Major Producer and Their Market Share
  • China's Brain Cancer Treatment Drugs Imports and Exports

V. BRAIN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Brain Cancer Treatment Drugs Sales Volume
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • China's Brain Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Specialty Output by Ownership
  • China's Imports and Exports

V. BRAIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Brain Cancer Treatment Drugs Sales Volume by Drugs Classification in 2008
  • Brain Cancer Treatment Drugs Sales Volume

IV. BRAIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Brain Cancer Treatment Drugs Sales Volume in China
  • Brain Cancer Treatment Drugs Sales Volume by Type
  • Alkylating Agents Sales Volume
  • Antimetabolites Sales Volume
  • Anti-Tumor Antibiotics Sales Volume
  • Hormones Sales Volume
  • Mitotic Inhibitors Sales Volume
  • Steroids Sales Volume
  • Drugs Aimed at Reducing Drug Resistance Sales Volume
  • Anti-Angiogenesis Inhibitors Sales Volume
  • Growth Factor Inhibitors Sales Volume
  • Total Brain Cancer Treatment Drugs Import and Export

V. BRAIN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Brain Cancer Treatment Drugs Sales Volume

VI. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Liver Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
    • Key Economic Indicators
    • Industrial Output
    • Population and Labor
    • Foreign Investment
    • Foreign Trade
  • Financial and Tax Regulations
    • Banking System and Regulations
    • Foreign Exchange
    • Taxes, Tariff and Custom Duties
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. LIVER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Liver Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Liver Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. LIVER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Liver Cancer Overview
  • Global Liver Treatment Drugs Market Overview
  • China's Liver Treatment Market Overview by Classification
  • Chemotherapy Drug
    • Alkylating Agent
    • Antibiotics
    • Antimetabolites
    • Plant-originated Anticancer Drugs
  • Platinum Agent
    • Monoclonal Antibodies
    • Immunomodulator
  • Interferon alfa-2B
  • Interleukin -2
  • Group A streptococcus
    • BCG
  • Other Immunomodulator
    • Tradition Chinese Medicine
    • Other New Drugs
  • Liver Cancer Treatment Drugs Import and Export by Classification
    • Liver Cancer Treatment Drugs Import
    • Liver Cancer Treatment Drugs Export
  • Market Overview by Producers
  • Pricing Trend

V. LIVER CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Liver Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
    • China's Distribution System
    • Liver Cancer Treatment Drugs Distribution Channels
    • Transportation and Freight Infrastructure
    • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

II. LIVER CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Profiles of Liver Cancer Treatment Drugs Producers

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

VI. LIVER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Liver Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Liver Cancer Treatment Drugs Producer Sales Volume and Their
  • Market Share
  • Major Foreign Investment in China

IV. LIVER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Liver Cancer Treatment Drugs Import by Country
  • Liver Cancer Treatment Drugs Export by Country
  • Liver Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Liver Cancer Treatment Drugs Import by Drugs Classification
  • Liver Cancer Treatment Drugs Export by Drugs Classification
  • Liver Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share

V. LIVER CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

VII. INTRODUCTION

  • Liver Cancer Treatment Drugs Sales Volume

VIII. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

IX. LIVER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Liver Cancer Treatment Drugs Sales Volume
  • Liver Cancer Treatment Drugs Sales Volume by Drugs Classification

X. LIVER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Liver Cancer Treatment Drugs Sales Volume
  • Liver Cancer Treatment Drugs Import
  • Liver Cancer Treatment Drugs Import by Country
  • Liver Cancer Treatment Drugs Export
  • Liver Cancer Treatment Drugs Export by Country
  • Liver Cancer Treatment Drugs Sales Volume by Classification
  • Chemotherapy Drug Sales Volume and Market Share
  • Immunomodulator Sales Volume and Market Share
  • Traditional Chinese Medicine Sales Volume and Market Share
  • Other New Drugs Sales Volume and Market Share
  • Liver Cancer Treatment Drugs Import by Classification
  • Chemotherapy Drug Import Volume and Market Share
  • Immunomodulator Import Volume and Market Share
  • Other New Drugs Import Volume and Market Share
  • Liver Cancer Treatment Drugs Export by Drugs Classification
  • Plant-originated Anticancer Drugs Export Volume and Market Share
  • Antibiotics Export Volume and Market Share
  • Antimetabolites Export Volume and Market Share
  • Traditional Chinese Medicine Export Volume and Market Share

VII. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Bladder Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
    • Key Economic Indicators
    • Industrial Output
    • Population and Labor
    • Foreign Investment
    • Foreign Trade
  • . Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Bladder Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Bladder Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Bladder Cancer Overview
  • Bladder Cancer Treatment Drugs Market Overview
  • Bladder Cancer Treatment Drugs Market Overview by Classification
    • Intraluminal Perfusion Agents
    • Unilateral Chemotherapy Drug
  • First-line Chemotherapy Drug
    • Immunomodulator
  • Other Drugs
    • Bladder Cancer Treatment Drugs Import and Export by Classification
  • . Bladder Cancer Treatment Drugs Import
  • . Bladder Cancer Treatment Drugs Export
  • Market Overview by Drug's Active Principle
  • Market Overview by Producers
  • Pricing Trend

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Bladder Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
    • China's Distribution System
    • Bladder Cancer Treatment Drugs Distribution Channels
    • Transportation and Freight Infrastructure
    • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

III. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Profiles of Bladder Cancer Treatment Drugs Producers

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

VII. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Top 14 Bladder Cancer Treatment Drugs Sales Volume and Market Share
  • Bladder Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Bladder Cancer Treatment Drugs Producer Sales Volume and Their Market Share
  • Major Foreign Investment in China

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Bladder Cancer Treatment Drugs Import by Country
  • Bladder Cancer Treatment Drugs Export by Country
  • Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Bladder Cancer Treatment Drugs Import by Drugs Classification
  • Bladder Cancer Treatment Drugs Export by Drugs Classification
  • Top 14 Bladder Cancer Treatment Drugs Medication Value and Their Market Share
  • Top 14 Bladder Cancer Treatment Drugs Sales Volume and Their Market Share
  • Bladder Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

XI. INTRODUCTION

  • Bladder Cancer Treatment Drugs Sales Volume

XII. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

XIII. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Bladder Cancer Treatment Drugs Sales Volume
  • Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification in 2008
  • Top 14 Bladder Cancer Treatment Drugs Market Share

XIV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Bladder Cancer Treatment Drugs Sales Volume
  • Bladder Cancer Treatment Drugs Import
  • Bladder Cancer Treatment Drugs Import by Country
  • Bladder Cancer Treatment Drugs Export
  • Bladder Cancer Treatment Drugs Export by Country
  • Bladder Cancer Treatment Drugs Sales Volume by Classification
  • Intraluminal Perfusion Agents Sales Volume and Market Share
  • Unilateral Chemotherapy Drug Sales Volume and Market Share
  • First-Line Chemotherapy Drug Sales Volume and Market Share
  • Immunomodulator Sales Volume and Market Share
  • Other Drugs Sales Volume and Market Share
  • Bladder Cancer Treatment Drugs Import by Classification
  • Unilateral Chemotherapy Drug Import and Market Share
  • First-Line Chemotherapy Drug Import and Market Share
  • Intraluminal Perfusion Agents Import and Market Share
  • Immunomodulator Import and Market Share
  • Other Drugs Import and Market Share
  • Bladder Cancer Treatment Drugs Export by Drugs Classification
  • Unilateral Chemotherapy Drug Export and Market Share
  • First-Line Chemotherapy Drug Export and Market Share
  • Intraluminal Perfusion Agents Export and Market Share
  • Immunomodulator Export and Market Share

VIII. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Kidney Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

VIII. BUSINESS ENVIRONMENT

  • Economic Outlook
    • Key Economic Indicators
    • Industrial Output
    • Population and Labor
    • Foreign Investment
    • Foreign Trade
  • . Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

IX. KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Kidney Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Driver
  • Kidney Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producer Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
    • Sales Volume of Kidney Cancer Treatment Drugs by Region
    • Kidney Cancer Treatment Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume
    • Alkylating Agents
  • Antimetabolites
  • Anti-Tumor Antibiotics
  • Steroids
  • Immunotherapy Drug
  • Cytokines
  • Cancer Vaccines
  • Targeted Therapy Drugs Sales Volume
  • Monoclonal Antibody
  • Small Molecules Drug
  • Growth Factor Inhibitors
    • Kidney Cancer Treatment Drugs Imports and Exports
    • Pricing Trend

V. KIDNEY CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Kidney Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
    • China's Distribution System
    • Kidney Cancer Treatment Drugs Distribution Channels
    • Transportation and Freight Infrastructure
    • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

II. KIDNEY CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Kidney Cancer Treatment Drugs Producer Profiles and Directory
  • Major End-Users

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

XV. KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Kidney Cancer Treatment Drugs Sales Volume and Market Share by Drugs Classification in 2008
  • Kidney Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Kidney Cancer Treatment Drugs Producer Sales Volume
  • Major Foreign Investment in China

XVI. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Kidney Cancer Treatment Drugs Sales Volume
  • Demand of Kidney Cancer Treatment Drugs by Region
  • Chemotherapy Drugs Sales Volume and Market Share by Drugs Classification
  • Alkylating Agents Sales Volume
  • Alkylating Agents Major Producer and Their Market Share
  • Antimetabolites Sales Volume
  • Antimetabolites Major Producer and Their Market Share
  • Anti-Tumor Antibiotics Sales Volume
  • Anti-Tumor Antibiotics Major Producer and Their Market Share
  • Steroids Sales Volume
  • Steroids Major Producer and Their Market Share
  • Immunotherapy Drugs Sales Volume and Market Share by Drugs Classification
  • Cytokines Sales Volume
  • Cytokines Major Producer and Their Market Share
  • Cancer Vaccines Sales Volume
  • Cancer Vaccines Major Producer and Their Market Share
  • Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Monoclonal Antibody Sales Volume
  • Monoclonal Antibody Major Producer and Their Market Share
  • Small Molecules Drug Sales Volume
  • Small Molecules Drug Major Producer and Their Market Share
  • Growth Factor Inhibitors Sales Volume
  • Growth Factor Inhibitors Major Producer and Their Market Share
  • China's Kidney Cancer Treatment Drugs Imports and Exports

V. KIDNEY CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Kidney Cancer Treatment Drugs Sales Volume
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • China's Kidney Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Specialty Output by Ownership
  • China's Imports and Exports

X. KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Kidney Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Kidney Cancer Treatment Drugs Sales Volume in China

XI. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Kidney Cancer Treatment Drugs Sales Volume in China
  • Kidney Cancer Treatment Drugs Sales Volume by Type
  • Chemotherapy Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume by Drugs Classification
  • Alkylating Agents Sales Volume
  • Antimetabolites Sales Volume
  • Anti-Tumor Antibiotics Sales Volume
  • Steroids Sales Volume
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs Classification
  • Cytokines Sales Volume
  • Cancer Vaccines Sales Volume
  • Targeted Therapy Drug Sales Volume
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Monoclonal Antibody Sales Volume
  • Small Molecules Drug Sales Volume
  • Growth Factor Inhibitors Sales Volume
  • Total Kidney Cancer Treatment Drugs Import and Export

XII. KIDNEY CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Kidney Cancer Treatment Drugs Sales Volume

XIII. MARKETING STRATEGIES

  • China's Distribution Channel

Chinese Markets for Skin Cancer Treatment Drugs

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

VI. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
    • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. SKIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Skin Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Driver
  • Skin Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
    • Sales Volume of Skin Cancer Treatment Drugs by Region
    • Skin Cancer Treatment Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume
    • Fluorouracil
  • Bleomycin
  • Cisplatin
  • Mitomycin
  • Retinoids
  • Immunotherapy Drug
  • α-Interferon
  • Interleukin
  • Cancer Vaccines
  • Photodynamic Therapy Drugs
    • Skin Cancer Treatment Drugs Imports and Exports
    • Pricing Trends

V. CHINA SKIN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Skin Cancer Treatment Drugs Markets Outlook
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
    • China's Distribution System
    • Skin Cancer Treatment Drugs Distribution Channels
    • Transportation and Freight Infrastructure
    • Communications
  • China's Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

I. SKIN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Skin Cancer Treatment Drugs Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

IV. SKIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Skin Cancer Treatment Drugs Sales Volume and Market Share by Drugs Classification in 2008
  • Skin Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Skin Cancer Treatment Drugs Producer Sales Volume
  • Major Foreign Investment in China

V. SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Skin Cancer Treatment Drugs Sales Volume
  • Demand of Skin Cancer Treatment Drugs by Region
  • Chemotherapy Drugs Sales Volume and Market Share by Drugs Classification
  • Fluorouracil Sales Volume
  • Fluorouracil Major Producer and Their Market Share
  • Bleomycin Sales Volume
  • Bleomycin Major Producer and Their Market Share
  • Cisplatin Sales Volume
  • Cisplatin Major Producer and Their Market Share
  • Mitomycin Sales Volume
  • Mitomycin Major Producer and Their Market Share
  • Retinoids Sales Volume
  • Retinoids Major Producer and Their Market Share
  • Immunotherapy Drugs Sales Volume and Market Share by Drugs Classification
  • α- Interferon Sales Volume
  • α- Interferon Major Producer and Their Market Share
  • Interleukin Sales Volume
  • Interleukin Major Producer and Their Market Share
  • Cancer Vaccines Sales Volume
  • Cancer Vaccines Major Producer and Their Market Share
  • Photodynamic Therapy Drugs Sales Volume and Market Share by Drugs Classification
  • China's Skin Cancer Treatment Drugs Imports and Exports

V. SKIN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Skin Cancer Treatment Drugs Sales Volume
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • China's Skin Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Specialty Output by Ownership
  • China's Imports and Exports

VII. SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Skin Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Skin Cancer Treatment Drugs Sales Volume in China

VIII. SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Skin Cancer Treatment Drugs Sales Volume in China
  • Skin Cancer Treatment Drugs Sales Volume by Type
  • Chemotherapy Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume by Drugs Classification
  • Fluorouracil Sales Volume
  • Bleomycin Sales Volume
  • Cisplatin Sales Volume
  • Mitomycin Sales Volume
  • Retinoids Sales Volume
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs Classification
  • α- Interferon Sales Volume
  • Interleukin Sales Volume
  • Cancer Vaccines Sales Volume
  • Photodynamic Therapy Drugs Sales Volume
  • Photodynamic Therapy Drugs Sales Volume by Drugs Classification
  • Growth Factor Inhibitors Sales Volume
  • Total Skin cancer treatment drugs Import and Export

IX. SKIN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Skin Cancer Treatment Drugs Sales Volume

X. MARKETING STRATEGIES

  • China's Distribution Channel
Show More
Pricing